ILC Dover Creates What's Next in Pharmaceutical Processing

(PRLEAP.COM) ILC Dover is pleased to introduce a new innovation in the pharmaceutical processing arena.

Our G2Pac, the Smart FIBC, is the next generation technology for cGMP powder transfer operations. Eclipsing the traditional FIBC, the G2Pac is smart engineered to address the issues that arise from uncontrolled processes, including compromised facility cleanliness, cross contamination risks and employee exposure to unnecessary hazards. Improved processing and direct operational cost savings result from reductions in product loss, cleaning validation, and water/solid waste disposal. We invite you to visit www.ilcdover.com to view more details on this Smart FIBC. Please contact us at customer_service@ilcdover.com for more information regarding how this product could enhance your processing capabilities.

—Man landed on the moon; we created the spacesuit.
—Researchers develop wonder drugs; we aid in safe production.
—Rovers explore Mars; we help them land safely.

ILC Dover: creating what’s next



Contact Information
Juanda Duley
ILC Dover
302.335.3911 ext. 470
Email ILC Dover

About This News Release

If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.

PR Leap disclaims any content found in news releases. Issuers of news releases are solely responsible for the accuracy of their content.

© 2005 Condesa, Inc. All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service. Copyright / IP Policy